Sarcopenia study in women at different life stages
Part of Brain & nervous system clinical trials.
This trial looks at muscle loss (sarcopenia) in women who are pre-menopause or post-menopause, and whether hormone replacement therapy affects it. It aims to understand how muscle health changes over a woman's life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman attending a gynecology clinic at the study center.
- You are either pre-menopause or post-menopause (with or without hormone therapy).
- You have given consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
This study tests whether a supervised exercise program can help women who have finished cancer treatment improve muscle strength and function. It may be a good option if you feel weak or have lost muscle.
This study looks at muscle loss (sarcopenia) in people with multiple sclerosis. It aims to understand what factors are linked to muscle loss, which could help improve care.
This study looks at how a program of different exercises (like strength and balance training) might improve muscle quality in older women. It may help you become stronger and move better.
This study checks for muscle loss (sarcopenia) in people aged 65 or older who are waiting for hip replacement surgery. It aims to see how common muscle loss is and may help improve care before and after surgery.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.